Sten Verland

General Partner & Founder at Sunstone Capital A/S

Sten Verland

Sten Verland

General Partner & Founder at Sunstone Capital A/S

Overview
Career Highlights

ACE BioSciences A/S
CytoTrack ApS
Genobiotix ApS

RelSci Relationships

674

Number of Boards

21

Birthday

1957

Age

64

Contact Data
Trying to get in touch with Sten Verland? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Sten Verland likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at LSP Management Group BV

Relationship likelihood: Strong

Managing Partner at Sunstone Capital A/S

Relationship likelihood: Strong

Managing Partner at Sunstone Capital A/S

Relationship likelihood: Strong

Managing Partner at Sunstone Capital A/S

Relationship likelihood: Strong

Founder at Anergis SA

Relationship likelihood: Strong

Partner at Sunstone Capital A/S

Relationship likelihood: Strong

Venture Partner at Wellington Partners GmbH

Relationship likelihood: Strong

Medical Director at StemCare A/S

Relationship likelihood: Strong

Managing Partner at Kurma Partners SA

Relationship likelihood: Strong

Chief Executive Officer at Meta-IQ

Relationship likelihood: Strong

In The News
Global Banking News
October 31, 2018
Cantargia appoints members of nomination committee
PR Newswire
August 26, 2013
Chiesi Group to Acquire Zymenex
Paths to Sten Verland
Potential Connections via
Relationship Science
You
Sten Verland
General Partner & Founder at Sunstone Capital A/S
Education
Master of Science in Biology & Mathematics

With over 40,000 students and more than 9,000 employees, the University of Copenhagen is the largest institution of research and education in Denmark. The purpose of the University to quote the University Statute is to conduct research and provide further education to the highest academic level.

Career History
General Partner & Founder
2007 - Current

Sunstone is an active manager which provides equity funding for early-stage capital requirements, and provides management support. The firm targets companies operating in the technology and life sciences sector, and industries such as biotechnology, pharmaceuticals, and information technology services. Sunstone invests in companies located in Denmark and Northern Europe, and looks to take minority stake positions in its investments, as well as a seat on the board.

Director
2003 - Current

StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark.

Chief Executive Officer & Founder
1994 - Current

Verland Capital is an active manager which provides equity funding for pre-seed and seed-stage capital requirements, as well as providing management support. The firm invests in young companies operating within life science and medtech, and industries such as biotechnology and pharmaceuticals. Verland Capital focuses on companies located in Denmark, Europe, and Northern America, and looks to take minority stake positions in its investments, as well as a seat on the board.

Boards & Committees
Director
2003 - Current

StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark.

Director
Current

Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark.

Chairman
Prior

ACE BioSciences A/S engages in the research and experimental development on biotechnology. It offers medical research, production, and sale of medical products. The company was founded on September 15, 2000 and is headquartered in Hillerød, Denmark.

Transactions
Details Hidden

Merck & Co., Inc. purchases Rigontec GmbH from NRW.Bank (Private Equity), Wellington Partners GmbH, Forbion Capital Partners Management Holding BV, High-Tech Gründerfonds Management GmbH, Sunstone Capital A/S, Boehringer Ingelheim Venture

Details Hidden

Chiesi Farmaceutici SpA, Chiesi Ltd. purchase Zymenex Holding A/S from Sunstone Capital A/S

Investments
Details Hidden

Nordic Vaccine A/S engages in the development and commercialization of vaccines for prophylactic and therapeutic use. It offers Posintro that combines delivery and immunological properties for the development of prophylactic and therapeutic vaccines. The firm also provides needle free delivery systems, including TransVac, a novel patch system for pain-free, non-invasive, and transdermal delivery of vaccines. The company was founded in 2001 and is headquartered in Copenhagen, Denmark.

Details Hidden

SYNARC Holdings, Inc., part of BioClinica, Inc., is a company headquartered in Newark, CA, that provides medical image analysis, subject recruitment and biochemical marker services.

Details Hidden
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sten Verland. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sten Verland's profile does not indicate a business or promotional relationship of any kind between RelSci and Sten Verland.